Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer

被引:20
|
作者
Schreiner, Waldemar [1 ]
Dudek, Wojciech [1 ]
Lettmaier, Sebastian [2 ]
Fietkau, Rainer [2 ]
Sirbu, Horia [1 ]
机构
[1] Friedrich Alexander Univ Erlangen Nuremberg, Univ Hosp, Div Thorac Surg, Erlangen, Germany
[2] Friedrich Alexander Univ Erlangen Nuremberg, Univ Hosp, Dept Radiat Oncol, Erlangen, Germany
来源
THORACIC AND CARDIOVASCULAR SURGEON | 2018年 / 66卷 / 02期
关键词
salvage surgery lung cancer; definitive chemoradiation therapy; local failure; STAGE-IIIA; CHEMORADIOTHERAPY; RECURRENT; OUTCOMES; REIRRADIATION; RESECTION; RADIOTHERAPY; 2ND-LINE;
D O I
10.1055/s-0037-1606597
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The incidence of local failure and residual tumor after definitive chemoradiation therapy (dCRT) for locally advanced non-small-cell lung cancer remains high, irrespective of applied radiation dose (>59 Gy). So-called salvage surgery has been suggested as a feasible treatment option after failure of definitive chemoradiation for locally advanced non-small cell lung cancer (NSCLC). Experience with salvage lung surgery (SLS) is limited, and long-term survival is rarely reported. Patient selection criteria for surgical lung salvage are not defined. The aim of this study was to assess postoperative survival and perioperative morbidity/mortality to identify prognostic factors and to define patient selection criteria. Patients and Methods Records of 13 consecutive patients with locally advanced NSCLC, who underwent SLS at a single institution between March 2011 and November 2016, were reviewed. Descriptive statistics were applied for patient characteristics and surgical and oncological outcome. Survival rates were calculated using the Kaplan-Meier method and were compared with the long-rank test. Results All patients initially received curative-intent definitive chemoradiation with median radiation doses of 66Gy (range 59.4-72) and concurrent platinum-based chemotherapy. Clinical tumor stage before definitive chemoradiation was IIIA in 9, IIIB in 3, IV in 1 patients. Median interval between definitive chemoradiation and salvage surgery was 6.7 months. Perioperative morbidity and 30-days-mortality was 38% and 7.7%, respectively. The median postoperative survival and estimated 5-year survival rate were 29.7 months and 46%, respectively. Conclusion SLS in patients with locally advanced non-small cell lung surgery following dCRT is feasible, prolongs long-term survival and allows local tumor control. Selection criteria remain undefined and patients should be considered surgical candidates during multidisciplinary team conference.
引用
收藏
页码:135 / 141
页数:7
相关论文
共 50 条
  • [1] Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
    Schreiner, Waldemar
    Dudek, Wojciech
    Lettmaier, Sebastian
    Fietkau, Rainer
    Sirbu, Horia
    [J]. JOURNAL OF CARDIOTHORACIC SURGERY, 2016, 11
  • [2] Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
    Waldemar Schreiner
    Wojciech Dudek
    Sebastian Lettmaier
    Rainer Fietkau
    Horia Sirbu
    [J]. Journal of Cardiothoracic Surgery, 11
  • [3] Salvage Lung Surgery Following Definitive Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer
    Schreiner, W.
    Dudek, W.
    Fietkau, R.
    Sirbu, H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2154 - S2154
  • [4] Long-Term Survival after Salvage SBRT for Recurrent or Secondary Non-Small Cell Lung Cancer after Surgery or Radiation Therapy
    He, C.
    Mei, L. Y.
    Cerra-Franco, A.
    Shiue, K.
    Liu, R.
    Langer, M.
    Rieger, K.
    Ceppa, D.
    Birdas, T.
    Kesler, K.
    Zellars, R. C.
    Lautenschlaeger, T.
    Kong, F. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E723 - E724
  • [5] A Competing Risk Model of First Failure Site after Definitive Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
    Nygard, Lotte
    Vogelius, Ivan R.
    Fischer, Barbara M.
    Kjaer, Andreas
    Langer, Seppo W.
    Aznar, Marianne C.
    Persson, Gitte F.
    Bentzen, Soren M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : 559 - 567
  • [6] Locoregional failure in locally advanced non-small cell lung cancer after definitive radiotherapy
    Jouglar, E.
    Isnardi, V.
    Goulon, D.
    Segura-Ferlay, C.
    Ayadi, M.
    Dupuy, C.
    Mahe, M. A.
    Claude, L.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S321 - S321
  • [7] Timing of of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer
    Gao, Sarah J.
    Corso, Christopher D.
    Wang, Elyn H.
    Blasberg, Justin D.
    Detterbeck, Frank C.
    Boffa, Daniel J.
    Decker, Roy H.
    Kim, Anthony W.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (02) : 314 - 322
  • [8] Salvage Surgery After Definitive Chemoradiotherapy for Non-Small Cell Lung Cancer
    Lampridis, Savvas
    [J]. ANNALS OF THORACIC SURGERY, 2021, 112 (06): : 2108 - 2108
  • [9] Salvage Surgery After Definitive Chemoradiotherapy for Non-small Cell Lung Cancer
    Casiraghi, Monica
    Maisonneuve, Patrick
    Piperno, Gaia
    Bellini, Roberto
    Brambilla, Daniela
    Petrella, Francesco
    De Marinis, Filippo
    Spaggiari, Lorenzo
    [J]. SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2017, 29 (02) : 233 - 241
  • [10] Salvage Surgery for Non-Small Cell Lung Cancer After Definitive Radiotherapy
    Shimizu, Kimihiro
    Ohtaki, Yoichi
    Suzuki, Kenji
    Date, Hiroshi
    Yamashita, Motohiro
    Iizasa, Toshihiko
    Ito, Hiroyuki
    Yoshimura, Kenichi
    Okada, Morihito
    Chida, Masayuki
    [J]. ANNALS OF THORACIC SURGERY, 2021, 112 (03): : 862 - 873